THE Food and Drug Administration (FDA) has given its emergency use authorization (EUA) approval to the coronavirus disease 2019 (Covid-19) vaccine made by British-Swedish drugmaker AstraZeneca.

During the Laging Handa media briefing on Thursday, FDA Director-General Rolando Enrique Domingo said that the interim data for AZD1222 from its ongoing phase three trials had an efficacy of 70 percent.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
Basic

Ad-supported access




  • Access to articles up to 30 days